CA2815507C - Methods for identifying target stimulation regions associated with therapeutic and non-therapeutic clinical outcomes for neural stimulation - Google Patents
Methods for identifying target stimulation regions associated with therapeutic and non-therapeutic clinical outcomes for neural stimulation Download PDFInfo
- Publication number
- CA2815507C CA2815507C CA2815507A CA2815507A CA2815507C CA 2815507 C CA2815507 C CA 2815507C CA 2815507 A CA2815507 A CA 2815507A CA 2815507 A CA2815507 A CA 2815507A CA 2815507 C CA2815507 C CA 2815507C
- Authority
- CA
- Canada
- Prior art keywords
- patient
- stimulation
- electrode
- computer
- axonal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000638 stimulation Effects 0.000 title claims abstract description 160
- 238000000034 method Methods 0.000 title claims abstract description 55
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 46
- 230000001537 neural effect Effects 0.000 title claims abstract description 33
- 230000037361 pathway Effects 0.000 claims abstract description 100
- 230000003376 axonal effect Effects 0.000 claims abstract description 64
- 210000004556 brain Anatomy 0.000 claims abstract description 61
- 238000009792 diffusion process Methods 0.000 claims abstract description 15
- 238000005094 computer simulation Methods 0.000 claims abstract description 7
- 210000003050 axon Anatomy 0.000 claims description 96
- 238000003384 imaging method Methods 0.000 claims description 26
- 230000007012 clinical effect Effects 0.000 claims description 22
- 210000001030 ventral striatum Anatomy 0.000 claims description 15
- 210000001009 nucleus accumben Anatomy 0.000 claims description 13
- 210000003484 anatomy Anatomy 0.000 claims description 11
- 238000002591 computed tomography Methods 0.000 claims description 11
- 210000002425 internal capsule Anatomy 0.000 claims description 10
- 230000036982 action potential Effects 0.000 claims description 6
- 210000005013 brain tissue Anatomy 0.000 claims description 5
- 230000001898 pallidal effect Effects 0.000 claims description 3
- 210000004001 thalamic nuclei Anatomy 0.000 claims description 3
- 230000008901 benefit Effects 0.000 abstract description 8
- 230000003213 activating effect Effects 0.000 abstract description 6
- 208000028552 Treatment-Resistant Depressive disease Diseases 0.000 description 38
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 description 35
- 230000004913 activation Effects 0.000 description 24
- 230000006872 improvement Effects 0.000 description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 208000035475 disorder Diseases 0.000 description 12
- 230000004044 response Effects 0.000 description 12
- 230000005684 electric field Effects 0.000 description 11
- 208000020016 psychiatric disease Diseases 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 8
- 210000001029 dorsal striatum Anatomy 0.000 description 8
- 239000000835 fiber Substances 0.000 description 8
- 230000000926 neurological effect Effects 0.000 description 7
- 238000004422 calculation algorithm Methods 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 5
- 210000004885 white matter Anatomy 0.000 description 5
- 210000001159 caudate nucleus Anatomy 0.000 description 4
- 238000002595 magnetic resonance imaging Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 208000012902 Nervous system disease Diseases 0.000 description 3
- 238000013528 artificial neural network Methods 0.000 description 3
- 230000002146 bilateral effect Effects 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005538 encapsulation Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000005056 cell body Anatomy 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 210000001787 dendrite Anatomy 0.000 description 2
- 238000002598 diffusion tensor imaging Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 238000001543 one-way ANOVA Methods 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000001103 thalamus Anatomy 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 1
- 208000020925 Bipolar disease Diseases 0.000 description 1
- YURDFQLSLRDNIX-UHFFFAOYSA-N C.CS Chemical compound C.CS YURDFQLSLRDNIX-UHFFFAOYSA-N 0.000 description 1
- 241001327708 Coriaria sarmentosa Species 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010054089 Depressive symptom Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000019022 Mood disease Diseases 0.000 description 1
- 102000004257 Potassium Channel Human genes 0.000 description 1
- 241000030538 Thecla Species 0.000 description 1
- CCAZWUJBLXKBAY-ULZPOIKGSA-N Tutin Chemical compound C([C@]12[C@@H]3O[C@@H]3[C@@]3(O)[C@H]4C(=O)O[C@@H]([C@H]([C@]32C)O)[C@H]4C(=C)C)O1 CCAZWUJBLXKBAY-ULZPOIKGSA-N 0.000 description 1
- 102100031083 Uteroglobin Human genes 0.000 description 1
- 108090000203 Uteroglobin Proteins 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011982 device technology Methods 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000004326 gyrus cinguli Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003007 myelin sheath Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 230000002450 orbitofrontal effect Effects 0.000 description 1
- 208000019906 panic disease Diseases 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000028173 post-traumatic stress disease Diseases 0.000 description 1
- 108020001213 potassium channel Proteins 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000002739 subcortical effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36082—Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
- A61N1/0529—Electrodes for brain stimulation
- A61N1/0534—Electrodes for deep brain stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/36182—Direction of the electrical field, e.g. with sleeve around stimulating electrode
- A61N1/36185—Selection of the electrode configuration
Landscapes
- Health & Medical Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Developmental Disabilities (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39460910P | 2010-10-19 | 2010-10-19 | |
| US61/394,609 | 2010-10-19 | ||
| PCT/US2011/056898 WO2012054612A1 (en) | 2010-10-19 | 2011-10-19 | Methods for identifying target stimulation regions associated with therapeutic and non-therapeutic clinical outcomes for neural stimulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2815507A1 CA2815507A1 (en) | 2012-04-26 |
| CA2815507C true CA2815507C (en) | 2021-07-20 |
Family
ID=44903419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2815507A Active CA2815507C (en) | 2010-10-19 | 2011-10-19 | Methods for identifying target stimulation regions associated with therapeutic and non-therapeutic clinical outcomes for neural stimulation |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8649845B2 (enExample) |
| EP (1) | EP2629840B1 (enExample) |
| JP (1) | JP2013540043A (enExample) |
| AU (1) | AU2011317137B9 (enExample) |
| CA (1) | CA2815507C (enExample) |
| ES (1) | ES2601890T3 (enExample) |
| WO (1) | WO2012054612A1 (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8666478B2 (en) * | 2009-10-08 | 2014-03-04 | The Medical College Of Wisconsin, Inc. | Method for determining locations of implanted electrodes with medical images |
| JP6027392B2 (ja) * | 2012-10-19 | 2016-11-16 | 株式会社ブリヂストン | 非空気入りタイヤ |
| JP2016523125A (ja) | 2013-05-30 | 2016-08-08 | グラハム エイチ． クリーシー | 局所神経性刺激 |
| US11229789B2 (en) | 2013-05-30 | 2022-01-25 | Neurostim Oab, Inc. | Neuro activator with controller |
| WO2015073411A1 (en) * | 2013-11-14 | 2015-05-21 | Boston Scientific Neuromodulation Corporation | Systems, methods, and visualization tools for stimulation and sensing of neural systems with system-level interaction models |
| WO2015149170A1 (en) * | 2014-03-31 | 2015-10-08 | Functional Neuromodulation, Inc. | Systems and methods for determining a trajectory for a brain stimulation lead |
| WO2015172853A1 (en) | 2014-05-16 | 2015-11-19 | Brainlab Ag | Inference transparency system for image-based clinical decision support systems |
| US10583293B2 (en) | 2014-09-09 | 2020-03-10 | Medtronic, Inc. | Therapy program selection for electrical stimulation therapy based on a volume of tissue activation |
| WO2016057544A1 (en) | 2014-10-07 | 2016-04-14 | Boston Scientific Neuromodulation Corporation | Systems, devices, and methods for electrical stimulation using feedback to adjust stimulation parameters |
| CA2969425A1 (en) * | 2014-12-01 | 2016-06-09 | The Feinstein Institute For Medical Research | Use of striatal connectivity patterns for evaluating antipsychotic agents |
| US11553840B2 (en) * | 2014-12-05 | 2023-01-17 | Rush University Medical Center | Electrode placement and treatment system and method of use thereof |
| US11026626B2 (en) | 2015-01-19 | 2021-06-08 | Brainlab Ag | Tissue-orientation-based simulation of deep brain stimulation |
| US10622107B2 (en) | 2015-02-13 | 2020-04-14 | Medtronic, Inc. | Tools for medical device configuration |
| US11077301B2 (en) | 2015-02-21 | 2021-08-03 | NeurostimOAB, Inc. | Topical nerve stimulator and sensor for bladder control |
| US10188863B2 (en) | 2015-02-26 | 2019-01-29 | Medtronic, Inc. | Therapy program selection for electrical stimulation therapy based on a volume of tissue activation |
| WO2017048908A1 (en) * | 2015-09-17 | 2017-03-23 | Albany Medical College | Stimulation of the ventral pallidum for the treatment of epilepsy |
| US10561848B2 (en) | 2015-10-13 | 2020-02-18 | Regents Of The University Of Minnesota | Systems and methods for programming and operating deep brain stimulation arrays |
| US10426949B2 (en) | 2016-10-26 | 2019-10-01 | Regents Of The University Of Minnesota | Systems and methods for optimizing programming and use of neuromodulation systems |
| JP6873238B2 (ja) * | 2016-11-17 | 2021-05-19 | ブレインラボ アーゲー | 時間同期した脳深部刺激の最適化 |
| JP6844019B2 (ja) * | 2017-02-28 | 2021-03-17 | ブレインラボ アーゲー | 脳深部刺激療法用電極の、刺激フィールドのモデルに基づく最適な選択及び配置 |
| US10716505B2 (en) | 2017-07-14 | 2020-07-21 | Boston Scientific Neuromodulation Corporation | Systems and methods for estimating clinical effects of electrical stimulation |
| US11723579B2 (en) | 2017-09-19 | 2023-08-15 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement |
| EP3706856A4 (en) | 2017-11-07 | 2021-08-18 | Neurostim Oab, Inc. | NON-INVASIVE NERVOUS ACTIVATOR WITH ADAPTIVE CIRCUIT |
| US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
| US12280219B2 (en) | 2017-12-31 | 2025-04-22 | NeuroLight, Inc. | Method and apparatus for neuroenhancement to enhance emotional response |
| US11478603B2 (en) | 2017-12-31 | 2022-10-25 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
| US10543361B2 (en) * | 2018-02-20 | 2020-01-28 | General Electric Company | System and method for localization of deep brain stimulation electrode via magnetic resonance imaging |
| US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
| EP3784331B1 (en) | 2018-04-27 | 2023-01-18 | Boston Scientific Neuromodulation Corporation | Multi-mode electrical stimulation systems and methods of making and using |
| WO2020056418A1 (en) | 2018-09-14 | 2020-03-19 | Neuroenhancement Lab, LLC | System and method of improving sleep |
| KR20220025834A (ko) | 2019-06-26 | 2022-03-03 | 뉴로스팀 테크놀로지스 엘엘씨 | 적응적 회로를 갖는 비침습적 신경 활성화기 |
| WO2021126921A1 (en) | 2019-12-16 | 2021-06-24 | Neurostim Solutions, Llc | Non-invasive nerve activator with boosted charge delivery |
| EP4291294A1 (en) | 2021-04-27 | 2023-12-20 | Boston Scientific Neuromodulation Corporation | Systems and methods for automated programming of electrical stimulation |
| EP4313269A1 (en) | 2021-06-15 | 2024-02-07 | Boston Scientific Neuromodulation Corporation | Methods and systems for estimating neural activation by stimulation using a stimulation system |
| EP4415809A2 (en) | 2021-12-10 | 2024-08-21 | Boston Scientific Neuromodulation Corporation | Systems and methods for generating and using response maps for electrical stimulation |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6246912B1 (en) * | 1996-06-27 | 2001-06-12 | Sherwood Services Ag | Modulated high frequency tissue modification |
| WO2001037717A2 (en) * | 1999-11-26 | 2001-05-31 | Applied Spectral Imaging Ltd. | System and method for functional brain mapping |
| US6778846B1 (en) * | 2000-03-30 | 2004-08-17 | Medtronic, Inc. | Method of guiding a medical device and system regarding same |
| US7305268B2 (en) * | 2000-07-13 | 2007-12-04 | Northstar Neurscience, Inc. | Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators |
| US7299096B2 (en) * | 2001-03-08 | 2007-11-20 | Northstar Neuroscience, Inc. | System and method for treating Parkinson's Disease and other movement disorders |
| WO2003005887A2 (en) * | 2001-07-11 | 2003-01-23 | Nuvasive, Inc. | System and methods for determining nerve proximity, direction, and pathology during surgery |
| US7565199B2 (en) * | 2002-12-09 | 2009-07-21 | Advanced Neuromodulation Systems, Inc. | Methods for treating and/or collecting information regarding neurological disorders, including language disorders |
| US7346382B2 (en) * | 2004-07-07 | 2008-03-18 | The Cleveland Clinic Foundation | Brain stimulation models, systems, devices, and methods |
| US8180601B2 (en) * | 2006-03-09 | 2012-05-15 | The Cleveland Clinic Foundation | Systems and methods for determining volume of activation for deep brain stimulation |
| US8209027B2 (en) | 2004-07-07 | 2012-06-26 | The Cleveland Clinic Foundation | System and method to design structure for delivering electrical energy to tissue |
| US20100331883A1 (en) * | 2004-10-15 | 2010-12-30 | Schmitz Gregory P | Access and tissue modification systems and methods |
| US8374696B2 (en) * | 2005-09-14 | 2013-02-12 | University Of Florida Research Foundation, Inc. | Closed-loop micro-control system for predicting and preventing epileptic seizures |
| US20100113959A1 (en) * | 2006-03-07 | 2010-05-06 | Beth Israel Deaconess Medical Center, Inc. | Transcranial magnetic stimulation (tms) methods and apparatus |
| US7949401B2 (en) * | 2006-04-11 | 2011-05-24 | Advanced Neuromodulation Systems, Inc. | Electromagnetic signal delivery for tissue affected by neuronal dysfunction, degradation, damage, and/or necrosis, and associated systems and methods |
| WO2008101128A1 (en) * | 2007-02-14 | 2008-08-21 | The Board Of Trustees Of The Leland Stanford Junior University | System, method and applications involving identification of biological circuits such as neurological characteristics |
| US8910638B2 (en) * | 2007-05-09 | 2014-12-16 | Massachusetts Institute Of Technology | Methods and apparatus for high-throughput neural screening |
| US8257684B2 (en) * | 2008-03-26 | 2012-09-04 | Neurosigma, Inc. | Methods for identifying and targeting autonomic brain regions |
| US8262714B2 (en) * | 2008-08-05 | 2012-09-11 | Advanced Neuromodulation Systems, Inc. | Techniques for selecting signal delivery sites and other parameters for treating depression and other neurological disorders, and associated systems and methods |
| US9095303B2 (en) * | 2009-03-23 | 2015-08-04 | Flint Hills Scientific, Llc | System and apparatus for early detection, prevention, containment or abatement of spread abnormal brain activity |
| US9597007B2 (en) * | 2009-07-21 | 2017-03-21 | The Regents Of The University Of California | Methods for the identification and targeting of brain regions and structures and treatments related thereto |
| WO2011068997A1 (en) * | 2009-12-02 | 2011-06-09 | The Cleveland Clinic Foundation | Reversing cognitive-motor impairments in patients having a neuro-degenerative disease using a computational modeling approach to deep brain stimulation programming |
| US8679009B2 (en) * | 2010-06-15 | 2014-03-25 | Flint Hills Scientific, Llc | Systems approach to comorbidity assessment |
| US8951192B2 (en) * | 2010-06-15 | 2015-02-10 | Flint Hills Scientific, Llc | Systems approach to disease state and health assessment |
-
2011
- 2011-10-19 US US13/317,459 patent/US8649845B2/en active Active
- 2011-10-19 WO PCT/US2011/056898 patent/WO2012054612A1/en not_active Ceased
- 2011-10-19 AU AU2011317137A patent/AU2011317137B9/en active Active
- 2011-10-19 ES ES11777000.8T patent/ES2601890T3/es active Active
- 2011-10-19 CA CA2815507A patent/CA2815507C/en active Active
- 2011-10-19 JP JP2013535044A patent/JP2013540043A/ja active Pending
- 2011-10-19 EP EP11777000.8A patent/EP2629840B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2815507A1 (en) | 2012-04-26 |
| AU2011317137B2 (en) | 2016-01-07 |
| EP2629840B1 (en) | 2016-08-17 |
| ES2601890T3 (es) | 2017-02-16 |
| AU2011317137A1 (en) | 2013-05-23 |
| AU2011317137B9 (en) | 2016-01-21 |
| JP2013540043A (ja) | 2013-10-31 |
| EP2629840A1 (en) | 2013-08-28 |
| US20120116211A1 (en) | 2012-05-10 |
| AU2011317137A8 (en) | 2013-08-01 |
| WO2012054612A1 (en) | 2012-04-26 |
| US8649845B2 (en) | 2014-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2815507C (en) | Methods for identifying target stimulation regions associated with therapeutic and non-therapeutic clinical outcomes for neural stimulation | |
| Lujan et al. | Axonal pathways linked to therapeutic and nontherapeutic outcomes during psychiatric deep brain stimulation | |
| Vanegas-Arroyave et al. | Tractography patterns of subthalamic nucleus deep brain stimulation | |
| Elias et al. | Probabilistic mapping of deep brain stimulation: insights from 15 years of therapy | |
| EP2419171B1 (en) | Neurocranial electrostimulation models | |
| Noecker et al. | StimVision v2: examples and applications in subthalamic deep brain stimulation for Parkinson’s disease | |
| Dembek et al. | Sweetspot mapping in deep brain stimulation: strengths and limitations of current approaches | |
| Maks et al. | Deep brain stimulation activation volumes and their association with neurophysiological mapping and therapeutic outcomes | |
| US8644946B2 (en) | System and method to define target volume for stimulation in brain | |
| Peña et al. | Multi-objective particle swarm optimization for postoperative deep brain stimulation targeting of subthalamic nucleus pathways | |
| WO2015061004A1 (en) | Neurocranial electrostimulation models, systems, devices and methods | |
| Lecy et al. | Neural pathways associated with reduced rigidity during pallidal deep brain stimulation for Parkinson’s disease | |
| US11291832B2 (en) | Patient-specific local field potential model | |
| Gunalan | Theoretical predictions of axonal pathways activated by subthalamic deep brain stimulation | |
| Åström | Modelling, simulation, and visualization of deep Brain stimulation | |
| García Cornet | Deep Brain Stimulation lead reconstruction and computer simulation based on neuroimaging for patients with Parkinson’s disease | |
| Cornet | Deep Brain Stimulation lead reconstruction and computer simulation based on neuroimaging for patients with Parkinson’s disease ANNEXES | |
| Patrick et al. | Modeling the volume of tissue | |
| Chaturvedi | Development of accurate computational models for patient-specific deep brain stimulation | |
| Sun et al. | Optimizing the delivery of deep brain stimulation using electrophysiological atlases and an inverse modeling approach | |
| Downar et al. | Magnetic resonance imaging in neuromodulation | |
| Lungu | DBSproc: An open source process for DBS electrode localization and tractographic analysis | |
| Teplitzky | Personalized computational models of deep brain stimulation | |
| Xiao | Experimental and Model-based Approaches to Directional Thalamic Deep Brain Stimulation | |
| Bikson et al. | High-resolution modeling assisted design of customized and individualized neuromodulation protocols |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20160816 |